These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7876335

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J, Ammanamanchi S, Ko TC, Brattain MG.
    Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668
    [Abstract] [Full Text] [Related]

  • 3. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM.
    Oncogene; 1996 Dec 05; 13(11):2447-57. PubMed ID: 8957087
    [Abstract] [Full Text] [Related]

  • 4. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
    Zhang F, Taipale M, Heiskanen A, Laiho M.
    Oncogene; 2001 Sep 13; 20(41):5888-96. PubMed ID: 11593394
    [Abstract] [Full Text] [Related]

  • 5. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells.
    Mal A, Poon RY, Howe PH, Toyoshima H, Hunter T, Harter ML.
    Nature; 1996 Mar 21; 380(6571):262-5. PubMed ID: 8637577
    [Abstract] [Full Text] [Related]

  • 6. Novel Cdk inhibitors restore TGF-beta sensitivity in cdk4 overexpressing epithelial cells.
    Soni R, Fretz H, Muller L, Schoepfer J, Chaudhuri B.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):794-800. PubMed ID: 10860833
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase.
    Kleinberger-Doron N, Shelah N, Capone R, Gazit A, Levitzki A.
    Exp Cell Res; 1998 Jun 15; 241(2):340-51. PubMed ID: 9637776
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC, Iglehart JD, Marks JR.
    Cell Growth Differ; 1994 Dec 15; 5(12):1301-7. PubMed ID: 7696178
    [Abstract] [Full Text] [Related]

  • 9. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A, Massagué J.
    Nature; 1997 May 22; 387(6631):417-22. PubMed ID: 9163429
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y, Kyprianou N.
    Cell Growth Differ; 1998 Feb 22; 9(2):185-93. PubMed ID: 9486855
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription.
    Alexandrow MG, Moses HL.
    Cancer Res; 1995 Sep 01; 55(17):3928-32. PubMed ID: 7641212
    [Abstract] [Full Text] [Related]

  • 12. Differential regulation of p34cdc2 and p33cdk2 by transforming growth factor-beta 1 in murine mammary epithelial cells.
    Fautsch MP, Eblen ST, Anders RA, Burnette RJ, Leof EB.
    J Cell Biochem; 1995 Aug 01; 58(4):517-26. PubMed ID: 7593274
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells.
    Ko TC, Sheng HM, Reisman D, Thompson EA, Beauchamp RD.
    Oncogene; 1995 Jan 05; 10(1):177-84. PubMed ID: 7824270
    [Abstract] [Full Text] [Related]

  • 14. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K, Griffin JD.
    Oncogene; 1995 Feb 16; 10(4):751-5. PubMed ID: 7862452
    [Abstract] [Full Text] [Related]

  • 15. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
    Schoecklmann HO, Rupprecht HD, Zauner I, Sterzel RB.
    Kidney Int; 1997 Apr 16; 51(4):1228-36. PubMed ID: 9083291
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes.
    Münger K, Pietenpol JA, Pittelkow MR, Holt JT, Moses HL.
    Cell Growth Differ; 1992 May 16; 3(5):291-8. PubMed ID: 1633111
    [Abstract] [Full Text] [Related]

  • 17. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.
    Koff A, Ohtsuki M, Polyak K, Roberts JM, Massagué J.
    Science; 1993 Apr 23; 260(5107):536-9. PubMed ID: 8475385
    [Abstract] [Full Text] [Related]

  • 18. Cyclin E and cyclin A as candidates for the restriction point protein.
    Dou QP, Levin AH, Zhao S, Pardee AB.
    Cancer Res; 1993 Apr 01; 53(7):1493-7. PubMed ID: 8384078
    [Abstract] [Full Text] [Related]

  • 19. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
    Tsai LH, Lees E, Faha B, Harlow E, Riabowol K.
    Oncogene; 1993 Jun 01; 8(6):1593-602. PubMed ID: 8502482
    [Abstract] [Full Text] [Related]

  • 20. TGF-beta induced G(1) cell cycle arrest requires the activity of the proteasome pathway. Transforming growth factor.
    Zhang F, Mönkkönen M, Roth S, Laiho M.
    Exp Cell Res; 2002 Dec 10; 281(2):190-6. PubMed ID: 12460649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.